Katrina’s Blog™
Insightful News and Commentary
On leadership, product innovation, talent cultivation, and ecosystem development across drugs, devices, diagnostics, and digital health tools.
Join us as we explore the latest trends and share expert insights to help you navigate the ever-evolving landscape of healthcare innovation.
Let’s embark on this journey of transformation together!

What is a Drug Master File (DMF)?
Jan 14, 2020 | Medical Products, Medicine, Product Development
A Drug Master File, or DMF, is a submission to the FDA used to provide confidential, detailed information about facilities, processes, or articles used in the manufacturing, processing, packaging, and storing of human drug products. There are four types of DMFs: Type...

Streamlined Process for Investigational In Vitro Devices
Jan 9, 2020 | Medical Products, Product Development
Codeveloped with Oncology Drugs The FDA released a procedural guidance in October 2019 which provides a streamlined process for submitting investigational in vitro devices (IVD) being codeveloped with investigational drugs in the same clinical protocol. The process...
Is Your Automated Electronic Defibrillator (AED) FDA Approved?
Jan 7, 2020 | Uncategorized
In 2015, the FDA published a final order establishing that all Automated Electronic Defibrillators (AEDs) and their accessories require pre-market approval (PMA) based on the adverse event report and product recall history of these devices. AEDs without PMA will no...
Bioanalytical Methods Templates for Your NDA/BLA
Jan 2, 2020 | Uncategorized
As we learned in the eCTD series of posts, the implementation of the standard by the FDA includes a series of technical specifications which define the format of an application and its sections. The latest technical specification, Bioanalytical Methods Templates,...
Happy Holidays, Everyone!
Dec 24, 2019 | Uncategorized
I'll take a brief break from posting new material on December 24th and 26th. Please browse some earlier posts and have a happy holiday!Reach out to me if you want to know more or discuss your medical product development...
Categories
Latest Posts
Outbreak! Combating the 2019-Novel Coronavirus (COVID-19)
Mar 31, 2020 | COVID
Chapter 8 - More Immediate Actions by the FDA to Increase Medical Supplies The COVID-19 outbreak has created shortages of medical supplies such as gloves, masks, hand sanitizer, and respiratory ventilators (the last essential for treatment of critical care patients)....
Outbreak! Combating the 2019-Novel Coronavirus (COVID-19)
Mar 26, 2020 | COVID
Chapter 7a – What to Do When There are Not Enough Lab Tests/Test Sites It’s pretty amazing how circumstances have changed in the past couple of weeks, and I’m sure the readers of this blog are adapting to the necessary changes to protect our communities. You may have...
Outbreak! Combating the 2019-Novel Coronavirus (COVID-19)
Mar 24, 2020 | COVID
Chapter 6 – Biomedical Mobilization Against COVID-19 The response of our biomedical community to the novel coronavirus outbreak has been impressive, and is illustrated in this slide from a JP Morgan webcast on COVID-19 and the Markets held on March 20th...
Standards Organizations Play a Role in Medical Product Regulation
Mar 19, 2020 | Medical Products, Medicine, Product Development
Regulatory bodies worldwide make use of consensus standards developed by independent organizations to establish best practices and conceptual harmony on specialized areas of expertise. Standards organizations for drugs include the regional Pharmacopeia USP, EP, and JP...